2023年6月20日 · What precautions should be placed on an elective surgery patient who was exposed to COVID-19 via a positive family member and/or cohabitant? The ASA and APSF Statement on Perioperative Testing for the COVID-19 Virus includes recommendations for both testing and screening of surgical patients.

2023年6月19日 · Guidance for the timing of surgery following SARS-CoV-2 infection needed reassessment given widespread vaccination, less virulent variants, contemporary evidence and a need to increase access to safe surgery. We, therefore, updated previous recommendations to assist policymakers, administrative staff, clinicians and, most importantly, patients.

2023年6月19日 · Elective surgeries should not occur within two weeks of a COVID-19 infection, allowing anesthesiologists and surgeons to assess how severe the patient’s symptoms are and to reduce unnecessary risk of transmitting the infection to health care professionals.

2022年3月1日 · Elective surgery should not take place for ≥10 days following SARS-CoV-2 infection, as the patient may be infectious and place staff and other patients at undue risk. Preoperative vaccination, ideally with three doses of mRNA-based vaccine, is highly recommended, as it is the most effective means of reducing infection severity.

Patients with the novel coronavirus disease 2019 (COVID-19) may be at increased risk of perioperative complications and may transmit the virus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) to clinicians and other patients. This topic will discuss preoperative evaluation and risk assessment and timing of surgery.

Patients with persistent symptoms and those with moderate-to-severe COVID-19 may require a longer delay than 7 weeks. Elective surgery should not take place within 10 days of diagnosis of SARS-CoV-2 infection, predominantly because the patient may be infectious, which is a risk to surgical pathways, staff and other patients.

Patients were grouped by time of surgery relative to COVID-19 test positivity: 0 to 4 weeks after COVID-19 (“early post-COVID-19”), 4 to 8 weeks after COVID-19 (“mid post-COVID-19”), >8 weeks after COVID-19 (“late post-COVID-19”), surgery at least 30 days before subsequent COVID-19 (“pre-COVID-19”), and surgery with no prior or ...

It is safe to proceed with major surgery two weeks after COVID-19 infection if there are no ongoing symptoms. For minor surgery, the procedure should be delayed until the infectious period is over (10 days). High risk patients should have an individualised risk assessment.

Urgent surgery should be performed for: obstructive or nearly-obstructing colorectal cancer (prefer diversion in rectal cancer), acutely transfusion-dependent tumors, cancers with pending evidence of local perforation and sepsis, post-surgical and post-colonoscopy complications .

The length of surgery significantly increased in the Cov19 group from 64 min (SD 34 min) to 71 min (SD 38 min). The number of short and long hospital stays (KrVD 2 or >4 days) significantly increased in the Cov19 group from 4 % to 20 % (short stay, p < 0.01) and from 23 % to 27 % (long stay, p < 0.01).